Seasoned Executive to Lead Strategy Across Capital Markets, Partner and Customer Development, and Global Operations SINGAPORE and SAN DIEGO, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Limited (NASDAQ: ...

NEW YORK, December 16, 2024--(BUSINESS WIRE)--As previously announced, JPMorgan Chase & Co. (NYSE ... be available on www.jpmorganchase.com under Investor Relations, Events & Presentations.

NEW YORK, December 16, 2024--(BUSINESS WIRE)--As previously announced, JPMorgan Chase & Co. (NYSE ... and presentation slides ...

Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patient ...

Valneva's CEO Thomas Lingelbach and CFO Peter Bühler will discuss the Company's commercial portfolio of vaccines, which is expected to generate €160 - €170 million in revenues in 2024, and highlight ...

JPMorgan Chase & Co. (NYSE: JPM) (“JPMorganChase” or the “Firm”) has declared dividends on the outstanding shares of the Firm’s Series CC and HH preferred stock. Information can be found ...

A live webcast of the conference presentation will be accessible through Repligen's Investor Relations website at www.repligen.com, and will be available for replay for a limited period of time ...

A JPMorgan Chase affiliate has sold a downtown D.C. office building to a Colorado investor at a steep discount.

NEW YORK--(BUSINESS WIRE)--JPMorgan Chase & Co. (NYSE: JPM) (“JPMorganChase” or the “Firm”) has declared dividends on the outstanding shares of the Firm’s Series CC and HH preferred stock. Information ...

JPMorgan Chase & Co. (NYSE: JPM) (“JPMorganChase” or the “Firm”) declared a quarterly dividend on the outstanding shares of the common stock of JPMorganChase. Information can be found on ...

M&A didn’t return as hoped for in 2024. The biopharma industry is heading into the J.P. Morgan Healthcare Conference next ...